Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

Special Report

NeurologyLive Peer Exchange

Medcast

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Expert Authors

FDA News

Features

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

Catch up on any of the neurology news headlines you may have missed over the course of April 2025, compiled all into one place by the NeurologyLive® team.

FDA Action Update, April 2025: Approvals, Expansion, and Authorization

Videos

The clinical associate professor of neurology and neurosurgery at NYU Langone talked about the promise of machine learning in identifying patients at high risk for hematoma expansion to guide care. [WATCH TIME: 2 minutes]

Tailoring Precision Medicine Treatment of Hemorrhagic Stroke Through Predictive Models: Kara R. Melmed, MD

Over long-term treatment, fenfluramine significantly reduced seizure frequency, increased seizure-free days, and improved quality of life in patients with Dravet syndrome.

Long-Term Extension Highlights Sustained Therapeutic Benefits of Fenfluramine

The professor of neurology at the University of Pennsylvania Perelman School of Medicine discussed the evolving role of noninvasive neuromodulation in promoting brain plasticity. [WATCH TIME: 3 minutes]

Enhancing Brain Plasticity by Personalized and Closed-Loop Neuromodulation: Roy H. Hamilton, MD, MS, FAAN

Clinical associate professor of neurology and neurosurgery at NYU Langone Health. 

Marco Meglio, Assistant Managing Editor for 

, has been with the team since October 2019. Follow him on Twitter 

This episode explores treatment considerations for patients already living with SMA, emphasizing individualized goals, medical complexity, and the value of subtle clinical improvements.

Setting Realistic Goals for Long-Standing Spinal Muscular Atrophy

, has been with the team since September 2022. Follow her on Twitter 

Evan L. Smith, PhD, assistant professor of Physical Medicine & Rehabilitation at University of Michigan, discussed how emotional wellbeing, motivation, and evidence-based therapies can significantly influence outcomes in MS.

Psychological Perspective on the Role of Mental Health in MS Rehabilitation and Care

In this episode, neurologists unpack the urgent and complex treatment decisions in newly diagnosed SMA, highlighting clinical factors, family input, and the importance of shared decision-making.

Starting Treatment in SMA: What Clinicians Need to Consider

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

LinkedIN

YouTube

Spotlight

AAN 2025

AD/PD 2025

MDA 2025

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

News Network

1rem

View

Allegheny Health Network

SAP Partners

Click below for the latest updated from Allegheny Health Network's Neuroscience Institute: 

At Allegheny Health Network (AHN), compassion and innovation meet. We bring together groundbreaking procedures, advanced technology, and the latest research to create new models of care that provide exceptional health care.

We’re focused on creating world-class, affordable health care close to home. In the last year or two, we’ve added more than 20 new facilities across western Pennsylvania. These include five new cancer centers, four neighborhood hospitals, expanded emergency departments at Saint Vincent and Jefferson hospitals, and a fifth Health + Wellness Pavilion.

And, we’ve opened a new 160-bed hospital in Wexford, as well as expanded our facilities at Allegheny General Hospital to house the new AHN Cancer Institute Academic Center.
With more than 200 active construction projects, we’re committed to improving access and quality of our services in the region.

The difference we make in the lives of our patients and their communities is #LivingProof.

SAP Partner

NOINDEX

NOFOLLOW

"Brainwaves" Latest from AHN Neuroscience Institute